Shandong Buchang Pharmaceuticals Co Ltd (603858) — Tangible Net Worth Ratio
Shandong Buchang Pharmaceuticals Co Ltd (603858) has a Tangible Net Worth Ratio of 73.9% as of September 2025. This metric is calculated by deducting intangible assets (CN¥2.63 Billion) from net assets (CN¥10.07 Billion) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See Shandong Buchang Pharmaceuticals Co Ltd current assets vs equity to evaluate short-term liquidity relative to the company's equity base.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Shandong Buchang Pharmaceuticals Co Ltd Tangible Net Worth Ratio (2011–2024)
This chart shows how Shandong Buchang Pharmaceuticals Co Ltd's Tangible Net Worth Ratio has changed across 14 annual periods from 2011 to 2024. As of September 2025, the ratio stands at 73.9%, reflecting net assets of CN¥10.07 Billion with intangible assets of CN¥2.63 Billion CNY. See 603858 defensive interval ratio to measure how many days the company can operate on defensive assets alone.
Annual Tangible Net Worth Ratio for Shandong Buchang Pharmaceuticals Co Ltd (2011–2024)
The table below presents the year-by-year Tangible Net Worth Ratio for Shandong Buchang Pharmaceuticals Co Ltd from 2011 to 2024, covering 14 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For the full company profile including market capitalisation, see Shandong Buchang Pharmaceuticals Co Ltd market capitalisation.
| Year | Tangible NW Ratio | Net Assets (CNY) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 74.7% | CN¥9.81 Billion | CN¥2.49 Billion | CN¥19.33 Billion | ▼ -4.9 pp |
| 2023 | 79.6% | CN¥11.38 Billion | CN¥2.33 Billion | CN¥20.89 Billion | ▼ -2.6 pp |
| 2022 | 82.2% | CN¥12.28 Billion | CN¥2.19 Billion | CN¥21.95 Billion | ▼ -3.0 pp |
| 2021 | 85.2% | CN¥14.45 Billion | CN¥2.14 Billion | CN¥23.99 Billion | ▲ +0.5 pp |
| 2020 | 84.7% | CN¥13.81 Billion | CN¥2.11 Billion | CN¥22.89 Billion | ▼ -0.9 pp |
| 2019 | 85.6% | CN¥13.79 Billion | CN¥1.98 Billion | CN¥21.19 Billion | ▲ +0.3 pp |
| 2018 | 85.3% | CN¥13.86 Billion | CN¥2.04 Billion | CN¥20.03 Billion | ▲ +0.6 pp |
| 2017 | 84.7% | CN¥13.22 Billion | CN¥2.02 Billion | CN¥19.20 Billion | ▼ -0.2 pp |
| 2016 | 84.9% | CN¥12.71 Billion | CN¥1.92 Billion | CN¥18.67 Billion | ▲ +11.4 pp |
| 2015 | 73.5% | CN¥7.26 Billion | CN¥1.92 Billion | CN¥15.76 Billion | ▼ -11.2 pp |
| 2014 | 84.7% | CN¥4.45 Billion | CN¥680.91 Million | CN¥9.10 Billion | ▼ -2.0 pp |
| 2013 | 86.7% | CN¥4.28 Billion | CN¥569.03 Million | CN¥6.94 Billion | ▼ -4.7 pp |
| 2012 | 91.4% | CN¥4.02 Billion | CN¥346.96 Million | CN¥5.67 Billion | ▲ +0.1 pp |
| 2011 | 91.3% | CN¥2.80 Billion | CN¥244.55 Million | CN¥4.44 Billion | — |